Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News QuidelOrtho Corp QDEL

QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies... see more

Recent & Breaking News (NDAQ:QDEL)

Quidel Announces Closing of Acquisition of Alere Triage® Assets Creating an Expanded Portfolio of Rapid Diagnostic Capabilities in Critical Care Settings

Business Wire October 6, 2017

Quidel Announces Early Termination of the Hart-Scott-Rodino Waiting Period for Its Pending Acquisition of Alere’s Triage® B-type Naturietic Peptide (BNP) Assay Business Run on Beckman Coulter Analyzers

Business Wire September 28, 2017

10 Biggest Mid-Day Gainers For Tuesday

Benzinga.com  September 19, 2017

Mid-Day Market Update: Bob Evans Farms Rises On Acquisition News; Mediwound Shares Plunge

Benzinga.com  September 19, 2017

The Market In 5 Minutes

Benzinga.com  September 19, 2017

Quidel Announces Revised Agreement for Its Pending Acquisition of Alere’s B-type Naturietic Peptide (BNP) Assay Business Run on Beckman Coulter Analyzers

Business Wire September 18, 2017

Quidel to Participate in the CEO Series Conference Call Hosted by Canaccord Genuity

Business Wire September 8, 2017

Quidel to Present at the 37th Annual Canaccord Genuity Growth Conference

Business Wire July 31, 2017

Quidel Reports Second Quarter 2017 Financial Results

Business Wire July 26, 2017

The Market In 5 Minutes

Benzinga.com  July 18, 2017

22 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  July 18, 2017

Wall Street's M&A Chatter From July 17: BorgWarner-Sevcon, Church & Dwight-Waterpik, Quidel-Alere Triage

Benzinga.com  July 18, 2017

Quidel Announces Definitive Agreement to Acquire Alere Triage® Assets

Business Wire July 17, 2017

Quidel to Hold Second Quarter 2017 Financial Results Conference Call on July 26, 2017

Business Wire July 14, 2017

Quidel Receives FDA Clearance and CLIA Waiver for Its Point-of-Care Sofia® 2 Instrument for Use with Sofia Respiratory Syncytial Virus (RSV) Assay

Business Wire June 28, 2017

Quidel’s Sofia® 2 Point-of-Care Immunoassay Analyzer Receives Multiple Awards from Good Design Australia®’s 2017 Good Design Awards®

Business Wire June 22, 2017

Quidel Receives the CE Mark for Its Thyretain® TBI Reporter BioAssay

Business Wire June 7, 2017

Quidel Receives FDA Clearance and CLIA Waiver for Its Point-of-Care Sofia® 2 Immunoassay Analyzer for Use with Sofia Influenza A+B Assay

Business Wire May 30, 2017

Quidel Receives PMDA Approval for Its Point-of-Care Sofia® Influenza A+B Assay

Business Wire May 24, 2017

Quidel Completes Acquisition of InflammaDry(R) and AdenoPlus(R) Eye-Health Businesses

Marketwired May 16, 2017